The first Myriad Genetics trade was made in Q2 2013.
Since then Jim Simons bought shares nineteen more times and sold shares on sixteen occasions. The investor completely sold their stake between Q4 2022 and Q1 2023.
Avg closing price
Price range
Sold -15 Thousand shares
Q1 2023
Avg closing price
$20.31
Price range
$15.26
-
$23.75
Sold 91.2% shares (-155 Thousand shares)
Q4 2022
Avg closing price
$18.63
Price range
$14.51
-
$20.99
Increased shares by 82.2% (+76.6 Thousand shares)
Q3 2022
Avg closing price
$22.95
Price range
$18.21
-
$27.88
Sold 2.4% shares (-2.27 Thousand shares)
Q2 2022
Avg closing price
$20.76
Price range
$16.45
-
$25.88
Increased shares by 151.4% (+57.5 Thousand shares)
Q1 2022
Avg closing price
$25.59
Price range
$22.67
-
$28.01
Sold 82.1% shares (-174 Thousand shares)
Q4 2021
Avg closing price
$28.97
Price range
$24.13
-
$32.63
Increased shares by 195.2% (+140 Thousand shares)
Q3 2021
Avg closing price
$33.21
Price range
$29.97
-
$36.66
New holding (+71.7 Thousand shares)
Q2 2021
Avg closing price
$28.89
Price range
$25.39
-
$32.61
Sold -49.5 Thousand shares
Q1 2021
Avg closing price
$28.38
Price range
$19.92
-
$31.60
Sold 54.2% shares (-58.5 Thousand shares)
Q4 2020
Avg closing price
$16.15
Price range
$12.16
-
$19.78
Increased shares by 107.6% (+56 Thousand shares)
Q3 2020
Avg closing price
$12.66
Price range
$11.25
-
$14.75
New holding (+52 Thousand shares)
Q2 2020
Avg closing price
$14.20
Price range
$10.69
-
$16.49
Sold -95.9 Thousand shares
Q1 2020
Avg closing price
$21.13
Price range
$9.78
-
$29.53
New holding (+95.9 Thousand shares)
Q4 2019
Avg closing price
$27.51
Price range
$20.93
-
$35.10
Sold -36.8 Thousand shares
Q3 2018
Avg closing price
$44.47
Price range
$37.57
-
$50.34
Sold 82.9% shares (-178 Thousand shares)
Q2 2018
Avg closing price
$33.78
Price range
$27.75
-
$40.17
Sold 0.9% shares (-2.01 Thousand shares)
Q1 2018
Avg closing price
$33.84
Price range
$28.83
-
$41.01
Increased shares by 35.7% (+57.1 Thousand shares)
Q4 2017